Home/Whitehawk Therapeutics/VP Research Placeholder
VR

VP Research Placeholder

Vice President of Research

Whitehawk Therapeutics

Therapeutic Areas

Whitehawk Therapeutics Pipeline

DrugIndicationPhase
WHK-001Advanced Solid Tumors (including Recurrent Glioblastoma and NSCLC)Phase 1/2